| Financial Year |
March 31 2023 |
| Monetary Funds |
488,046,403.44 |
| Held-for-trading Financial Assets |
198,199,734.51 |
| Notes Receivable |
-- |
| Accounts Receivable |
248,874,302.50 |
| Advances to Suppliers |
19,186,596.33 |
| Other Receivables |
19,612,469.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
936,739,679.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,974,200.51 |
| Total Current Assets |
2,101,893,597.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
252,046,680.00 |
| Fixed Assetes |
585,324,644.27 |
| Under-construction Projects |
149,523,146.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
158,437,935.92 |
| R&D expenses |
89,106,671.92 |
| Goodwill |
40,794,110.25 |
| Long-Term Deferred and Prepaid Expenses |
53,159,313.05 |
| Deferred Income Tax Assets |
75,682,673.80 |
| Other Non-Current Assets |
135,129,378.47 |
| Sub-Total of Non-Current Assets |
1,659,652,330.27 |
| Total Assets |
3,761,545,927.56 |
| Short-Term Loans |
677,373,624.70 |
| Trading Financial liabilities |
45,485.79 |
| Notes Payable |
109,841,282.33 |
| Accounts Payable |
135,969,621.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,623,337.07 |
| Taxes Payable |
9,644,962.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
189,715,210.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
103,864,900.30 |
| Other Current Liabilities |
1,484,847.96 |
| Sub-Total of Current Liabilities |
1,277,343,467.18 |
| Long-term Loans |
421,651,776.36 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
295,532,004.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
40,165,067.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
799,448,543.49 |
| Total Liabilities |
2,076,792,010.67 |
| Paid-In Capital(Or Share Stock) |
595,638,000.00 |
| Capital Surplus |
2,483,046,916.27 |
| Surplus Reserve |
68,560,890.84 |
| LESS:Treasury Stock |
167,833,570.00 |
| Undistributed Profits |
-1,530,060,889.86 |
| Minority Stockholder's Interest |
91,911,287.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,592,842,629.21 |
| Owner's Equity（Stockholder's Equity） |
1,684,753,916.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,761,545,927.56 |
